Title
For Blood And Money: Billionaires, Biotech, And The Quest For A Blockbuster Drug,New
Sold by Ergodebooks, an authorized reseller.
Returns accepted within 30 days | support@ergodebooks.com
Shipping Information
- Free Standard Shipping — United States only
- Processing Time: 1–3 business days
- Estimated Delivery: 3–5 business days after dispatch
- Double-boxed, fully insured & discreetly packaged
- Tracking number sent via email once dispatched
- Orders over $250 require signature upon delivery. Taxes calculated at checkout.
Returns & Refund
Returns accepted within 30 days of delivery.
Damaged or Defective Item
Free return shipping + replacement or full refund
Wrong Item Received
Free return shipping + replacement or full refund
Change of Mind
Return shipping at customer's expense · 25% restocking fee applies
Payment Option
One of Scientific American's Best Staff Reads of 2023A gripping business narrative and scientific thriller about what it takes to bring a wonder drug to marketand save countless lives.For Blood and Money tells the littleknown story of how an upstart biotechnology company created a oneinamillion cancer drug, and how members of the core teamdenied their share of the profitswent and did it again. In this epic saga of money and science, veteran financial journalist Nathan Vardi explains how the invention of two of the biggest cancer drugs in history became (for their backers) two of the greatest Wall Street bets of all time.In the multibilliondollar business of biotech, where pharmaceutical companies, the government, hedge funds, and venture capitalists have spent billions on funding, experimentation, and treatments, a single molecule can stop cancer in its tracksand make the people who find that rare molecule astonishingly rich. For Blood and Money follows a small team at a biotech startup in California, who have found one of these rare molecules. Their compound, known as a BTK inhibitor, seems to work on a vicious type of leukemia. When patients start rising from their hospice beds, the team knows theyre onto something big.What follows is a story of genius, pathos, and drama, in which vivid characters navigate a world of corporate intrigue and ambiguous morality. Vardis narrative immerses readers in the recent explosion of biotech startups. He describes the scientists, doctors, and investors who are risking everything to develop new, lifesaving treatments, and introduces suffering patients for whom the stakes are lifeordeath. A gripping nonfiction read, For Blood and Money illustrates why its so hard to bring new drugs to market, explains why they are so expensive, and examines how profitdriven venture capitalists are shaping the future of medicine.
⚠️ WARNING (California Proposition 65):
This product may contain chemicals known to the State of California to cause cancer, birth defects, or other reproductive harm.
For more information, please visit www.P65Warnings.ca.gov.
- Q: How many pages does the book have? A: The book has two hundred eighty-eight pages. This length provides a comprehensive narrative that covers the intricate details of the biotech industry.
- Q: What is the binding type of this book? A: The book is a hardcover edition. This format offers durability and a premium feel, making it ideal for readers who appreciate high-quality books.
- Q: What are the dimensions of the book? A: The book measures six point three inches in length, one point one inches in width, and nine point four one inches in height. These dimensions make it a manageable size for reading.
- Q: Who is the author of 'For Blood and Money'? A: The author is Nathan Vardi. He is a veteran financial journalist known for his insightful writing on biotechnology and finance.
- Q: What genre does this book belong to? A: The book falls under the genres of business narrative and scientific thriller. It combines elements of both to explore the world of biotech.
- Q: Is 'For Blood and Money' suitable for young readers? A: No, the book is not specifically targeted at young readers. Its themes and content are more appropriate for adults and older teens interested in science and business.
- Q: How can I use this book effectively? A: You can use this book for both educational and entertainment purposes. It's ideal for readers interested in the biotech industry, financial narratives, and real-life stories of innovation.
- Q: Is this book a good resource for understanding biotech? A: Yes, the book offers in-depth insight into the biotech industry. It explains complex concepts in a narrative format that is engaging and informative.
- Q: What themes are explored in this book? A: The book explores themes of innovation, corporate intrigue, and the moral dilemmas in the pharmaceutical industry. These themes provide a gripping backdrop to the narrative.
- Q: How should I store this book to keep it in good condition? A: Store the book upright in a cool, dry place. Avoid exposure to direct sunlight to prevent fading and keep it away from moisture to avoid damage.
- Q: Can I lend this book to others? A: Yes, you can lend this book to others. Just ensure it is returned in good condition to maintain its quality.
- Q: What if I receive a damaged copy of the book? A: If you receive a damaged copy, you should contact the seller for a return or exchange. Most sellers have policies in place to handle such issues.
- Q: Does this book contain any adult content? A: No, the book does not contain explicit adult content. However, it does discuss serious themes related to life and death in the context of medicine.
- Q: Is there a warranty or guarantee for this book? A: Typically, books do not come with a warranty. However, you can check with the seller for their return policy regarding unsatisfactory products.
- Q: What should I do if I have questions about the book's content? A: If you have questions about the book's content, consider looking for reviews or discussion forums online. Engaging with other readers can enhance your understanding.
- Q: Is this book a good choice for someone new to biotech topics? A: Yes, this book is a suitable choice for beginners. Its narrative style makes complex biotech topics more accessible to general readers.